*** MICK, $Pistol Pete$ & FRIENDS STOCK PICKS *** M F S P

[Avoid]

NASDAQ: TRPX cannabinoid-based drugs IPO

TEL AVIV, Israel, March 22, 2017 /PRNewswire/ --

Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its initial public offering in the United States of 2,000,000 American Depository Shares ("ADSs"). Each ADS, representing 40 ordinary shares of the Company, is offered at a price to the public of $6.00.